テレヘルス＆遠隔医療市場：コンポーネント（ソフトウェア＆サービス（RPM、リアルタイム）、ハードウェア（モニター））、デリバリー（オンプレミス、クラウドベース）、アプリケーション（Teleradiology、Telestroke、TelelCU）、エンドユーザー（プロバイダー、ペイヤー）、地域別 - 2028年までの世界予測

Telehealth & Telemedicine Market by Component (Software & Services (RPM, Real-Time), Hardware (Monitors)), Delivery (On-Premise, Cloud-Based), Application (Teleradiology, Telestroke, TelelCU), End User (Provider, Payer) & Region - Global Forecast to 2028

遠隔医療と遠隔健康市場は、2023年の1,204億米ドルから2028年には2,857億米ドルに達すると予測され、予測期間中の年平均成長率は23.2%である。遠隔医療と遠隔ヘルスの成長は、特に遠隔地における医療サービスへの... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年12月8日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	379	452	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

遠隔医療と遠隔健康市場は、2023年の1,204億米ドルから2028年には2,857億米ドルに達すると予測され、予測期間中の年平均成長率は23.2%である。遠隔医療と遠隔ヘルスの成長は、特に遠隔地における医療サービスへのアクセシビリティの向上と、接続性の向上やプラットフォームの強化などの継続的な技術進歩によって推進され、より良い患者エンゲージメントと転帰を促進する。

"クラウドベースの配信モードセグメントは、2022年に配信モード別に、遠隔医療と遠隔健康管理市場のかなりのシェアを占めた。"
クラウドベースの配信モードは、2022年に世界の遠隔医療と遠隔治療市場で78.2％の最大シェアを占めると予測されている。また、予測期間中の年平均成長率は28.6%と最も高くなると予測されている。クラウドベースの配信は、その固有の利点により遠隔医療と遠隔治療市場を支配している。クラウドソリューションが提供するアクセシビリティとスケーラビリティは、事実上どこからでも医療サービスを可能にし、遠隔地やサービスが行き届いていない地域のギャップを埋める。コスト効率はサブスクリプション・ベース・モデルによって向上し、予算に制約のある組織にとって魅力的なプラットフォームとなっている。強固なセキュリティ対策、コンプライアンス基準、シームレスな相互運用性により、クラウド環境は機密性の高い患者データの安全な保管場所となる。リアルタイムのコラボレーション、遠隔モニタリング機能、迅速な展開は、遠隔医療サービスの有効性をさらに高める。さらに、クラウドプラットフォームは、迅速な更新、災害復旧、事業継続性を保証し、進化する医療提供の状況において、クラウドプラットフォームが広く採用される原動力となっている。

"2022年、コンポーネント別では、ソフトウェアとサービスセグメントが遠隔医療・遠隔治療市場で大きなシェアを占めた。"
コンポーネント別では、ソフトウェア＆サービス分野が2022年の世界の遠隔医療・遠隔健康管理市場で71.3％の最大シェアを占めると予測されている。ソフトウェアとサービスセグメントは、遠隔医療と遠隔治療市場のコンポーネントとして大きなシェアを占めている。この隆盛は、ソフトウェア・アプリケーションと関連サービスが遠隔医療提供を促進する上で重要な役割を果たすことによる。遠隔医療プラットフォームは、バーチャル診察、患者モニタリング、シームレスなデータ交換を可能にする高度なソフトウェアソリューションに大きく依存している。さらに、遠隔医療相談サポート、データ分析、統合サービスのようなサポートサービスの提供は、ソフトウェアとサービスのコンポーネントの重要性をさらに強固なものにしている。遠隔医療と遠隔治療の展望が進化し続ける中、ソフトウェアとサービス部門は依然として要であり、市場の成長と効果に大きく貢献している。
「2022年、エンドユーザー別テレヘルス・遠隔医療市場ではプロバイダー分野がかなりのシェアを占める
2022年、プロバイダーセグメントは遠隔医療と遠隔治療市場で重要な役割を果たし、かなりのシェアに貢献した。この隆盛は、慢性疾患や高齢患者の遠隔モニタリングの採用増加、遠隔医療モニタリングデバイスの進歩、プロバイダーが提供する遠隔専門サービスの増加に起因する。

"2022年、テレヘルス・遠隔医療市場のアプリケーション別でテレラジオロジー分野が最大シェアを占める"
2022年、遠隔医療・遠隔診療市場において、遠隔放射線学分野が最大のシェアを占め、主要な貢献者として浮上した。画像診療の増加、医療提供者による遠隔画像診断ワークフロー導入の増加、遠隔画像診断診療の合理化と規制などの要因が市場成長を促進している。遠隔画像診断分野は、2022年には世界の遠隔医療・遠隔診断市場の22.2%という最大シェアを占めると予想されている。
「予測期間中、北米が大幅な成長率を目撃する。
世界市場は米国に牽引され、顕著なCAGR 24.3％を経験し、予測期間には2,897億米ドルの評価額に達する。この急成長は、慢性疾患の蔓延、高齢化、費用対効果の高い医療サービスなどの要因によって推進され、米国における遠隔医療と遠隔治療の成長に寄与している。医療インフラ、支出、革新的技術の増加により、市場は継続的に拡大している。政府の取り組みと主要ベンダーの積極的な関与が市場規模をさらに拡大し、2023年から2028年にかけての過去のCAGR 24.3%から大幅な伸びを示す。

主要参入企業の内訳は以下の通りである：
- 企業タイプ別：ティア1：45％、ティア2：30％、ティア3：25
- 役職別 - Cレベル：42%、ディレクターレベル：31%、その他：27
- 地域別 - 北米：32%、欧州：32%、アジア太平洋地域：26%、ROW-10

遠隔医療・遠隔治療ソリューション市場の主要企業
テレヘルスおよび遠隔医療市場における主なプレーヤーには、Koninklijke Philips, N.V（オランダ）、Medtronic plc（アイルランド）、GE Healthcare（米国）、Oracle（米国）、Siemens Healthcare GmbH（ドイツ）、Cisco Systems（米国）、旭化成株式会社（日本）、Iron Bow Technologies（米国）、American Well（米国）、Teladoc Health, Inc.(米国）、AMCヘルス（米国）、TeleSpecialists（米国）、Doctor On Demand by Included Health, Inc.(英国）、Medweb（米国）、VSee（米国）、Imedi Plus（中国）、Zipnosis（米国）、ACL Digital（米国）、iCliniq（米国）、Boston Scientific Cardiac Diagnostics Inc.（米国）、Resideo Technologies Inc.
調査範囲
この調査レポートは、遠隔医療と遠隔健康市場を分析し、コンポーネント、提供形態、アプリケーション、エンドユーザー、地域に基づいて、様々な市場セグメントの市場規模と今後の成長可能性を推定することを目的としています。また、この市場で事業を展開する主要企業の競争分析も行い、企業プロフィール、製品提供、最近の開発状況、主要市場戦略などを掲載しています。
レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業にとっても、市場の動向を把握する上で有益であり、ひいては市場シェアを拡大するのに役立つものと思われる。本レポートを購入された企業は、以下の戦略の1つまたは組み合わせを使用して、市場での地位を強化することができます。
本レポートは以下の洞察を提供する：
 主な促進要因（老年人口の増加と医療アクセス拡大の必要性、慢性疾患の有病率の上昇と遠隔医療・遠隔診療の費用対効果、医師不足、電気通信の進歩、政府の支援と意識の高まり）、阻害要因（地域による規制の違い、遠隔医療・遠隔医療における不正）、機会（感染症や伝染病対策における高い有用性、ブロックチェーン、AI、バーチャルアシスタントなどの革新的技術の利用）、課題（衛生や清潔さを把握できないことが遠隔医療・遠隔医療市場の成長に影響を与えている）。
 製品開発/イノベーション：テレヘルスと遠隔医療市場における今後の技術、研究開発活動、新製品発表に関する詳細な洞察。
 市場開発：有利な新興市場、コンポーネント、人口統計、エンドユーザー、地域に関する包括的情報。
 市場の多様化：テレヘルスおよび遠隔医療市場における製品ポートフォリオ、成長地域、最近の開発、投資に関する詳細な情報。
 競合評価：Koninklijke Philips, N.V (オランダ)、Medtronic plc (アイルランド)、GE Healthcare (米国)、Oracle (米国)、Siemens Healthcare GmbH (ドイツ)、Cisco Systems (米国) などのTelehealthおよび遠隔医療市場における主要企業の市場シェア、成長戦略、製品提供、能力を詳細に評価。

ページTOPに戻る

1 INTRODUCTION 48
1.1 STUDY OBJECTIVES 48
1.2 MARKET DEFINITION 48
1.2.1 TELEHEALTH 48
1.2.2 TELEMEDICINE 49
1.3 INCLUSIONS & EXCLUSIONS 49
1.4 MARKET SCOPE 50
1.4.1 MARKETS COVERED 50
1.4.2 REGIONS COVERED 51
1.4.3 YEARS CONSIDERED 51
1.4.4 CURRENCY CONSIDERED 52
1.5 RESEARCH LIMITATIONS 52
1.5.1 SCOPE-RELATED LIMITATIONS 52
1.5.2 METHODOLOGY-RELATED LIMITATIONS 52
1.6 STAKEHOLDERS 52
1.7 SUMMARY OF CHANGES 53
1.7.1 RECESSION IMPACT: TELEHEALTH & TELEMEDICINE MARKET 53
2 RESEARCH METHODOLOGY 54
2.1 RESEARCH DATA 54
FIGURE 1 RESEARCH METHODOLOGY: TELEHEALTH & TELEMEDICINE MARKET 54
FIGURE 2 RESEARCH DESIGN 55
2.1.1 SECONDARY DATA 55
2.1.1.1 Secondary sources 56
2.1.2 PRIMARY DATA 57
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION, AND REGION 58
2.1.2.1 Primary sources 58
2.1.2.2 Key insights from primary sources 58
2.2 MARKET SIZE ESTIMATION 59
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 59
FIGURE 5 ESTIMATION OF MARKET SIZE FOR REMOTE PATIENT MONITORING SOFTWARE & SERVICES THROUGH ADOPTION-BASED APPROACH 60
FIGURE 6 ESTIMATION OF MARKET SIZE FOR REAL-TIME INTERACTION SOFTWARE & SERVICES THROUGH ADOPTION-BASED APPROACH 60
FIGURE 7 ESTIMATION OF MARKET SIZE FOR STORE-AND-FORWARD SOFTWARE & SERVICES THROUGH ADOPTION-BASED APPROACH 61
FIGURE 8 ESTIMATION OF GLOBAL TELEHEALTH & TELEMEDICINE MARKET SIZE THROUGH ADOPTION-BASED APPROACH 61
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 63
FIGURE 9 DATA TRIANGULATION METHODOLOGY 63
2.4 STUDY ASSUMPTIONS 64
2.5 RISK ASSESSMENT 64
2.6 IMPACT OF ECONOMIC RECESSION ON TELEHEALTH & TELEMEDICINE MARKET 64
3 EXECUTIVE SUMMARY 66
FIGURE 10 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION) 66
FIGURE 11 TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2023 VS. 2028 (USD MILLION) 67
FIGURE 12 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 67
FIGURE 13 TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 68
FIGURE 14 REGIONAL SNAPSHOT: TELEHEALTH & TELEMEDICINE MARKET 69
4 PREMIUM INSIGHTS 70
4.1 TELEHEALTH & TELEMEDICINE MARKET OVERVIEW 70
FIGURE 15 SHORTAGE OF MEDICAL STAFF, RISE IN CHRONIC DISEASES, AND INCREASED GERIATRIC POPULATION TO DRIVE MARKET 70
4.2 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT AND COUNTRY, 2022 71
FIGURE 16 SOFTWARE & SERVICES SEGMENT AND US DOMINATED NORTH AMERICAN MARKET IN 2022 71
4.3 GEOGRAPHICAL GROWTH OPPORTUNITIES: TELEHEALTH & TELEMEDICINE MARKET 72
FIGURE 17 CHINA TO ACCOUNT FOR HIGHEST CAGR DURING FORECAST PERIOD 72
4.4 TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2021–2028 73
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD 73
4.5 DEVELOPED VS. EMERGING ECONOMIES: TELEHEALTH & TELEMEDICINE MARKET 73
FIGURE 19 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 73
5 MARKET OVERVIEW 74
5.1 INTRODUCTION 74
5.2 MARKET DYNAMICS 74
FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: TELEHEALTH & TELEMEDICINE MARKET 74
TABLE 1 MARKET DYNAMICS: IMPACT ANALYSIS 75
5.2.1 DRIVERS 76
5.2.1.1 Growing geriatric population and increasing need to expand healthcare access 76
TABLE 2 INCREASE IN POPULATION, 2022, 2030, AND 2050, BY MEDIUM SCENARIO (MILLION) 76
5.2.1.2 Rising prevalence of chronic conditions and cost-benefits of telehealth & telemedicine services 77
TABLE 3 CHRONIC DISEASES AND THEIR COST BURDEN IN US: POTENTIAL FOR SAVINGS 77
5.2.1.3 Shortage of skilled healthcare professionals 78
5.2.1.4 Advancements in telecommunication technologies 78
5.2.1.5 Increased government support and favorable reimbursement policies 78
5.2.2 RESTRAINTS 79
5.2.2.1 Regulatory variations across regions 79
TABLE 4 US: STATE-WISE REGULATORY REQUIREMENTS FOR TELEHEALTH 79
5.2.2.2 Increase in fraud in telehealth practices 80
5.2.2.3 Violation of medical ethics 81
5.2.3 OPPORTUNITIES 81
5.2.3.1 Increased utility of telemedicine against infectious diseases and epidemics 81
5.2.3.2 Use of blockchain technology in healthcare industry 81
5.2.3.3 Increased use of artificial intelligence and big data analytics 82
5.2.3.4 Growing demand for virtual care 83
5.2.4 CHALLENGES 84
5.2.4.1 Inability to maintain hygiene and cleanliness standards 84
5.2.4.2 Behavioral barriers, healthcare affordability, and lack of awareness 84
5.3 INDUSTRY TRENDS 85
TABLE 5 TRENDS IN TELEHEALTH & TELEMEDICINE MARKET 85
5.3.1 OVERVIEW OF USE CASES 86
TABLE 6 OVERVIEW OF TELEHEALTH USE CASES 88
5.4 TECHNOLOGY ANALYSIS 89
5.4.1 MACHINE LEARNING 89
5.4.2 ARTIFICIAL INTELLIGENCE 90
5.4.3 INTERNET OF THINGS 90
5.4.4 BLOCKCHAIN TECHNOLOGY 90
5.4.5 CLOUD COMPUTING 91
5.4.6 DATA ANALYTICS 91
5.4.7 EXTENDED REALITY 91
5.5 CASE STUDY ANALYSIS 92
5.5.1 CASE STUDY 1 92
5.5.2 CASE STUDY 2 93
5.6 ECOSYSTEM MARKET MAP 93
FIGURE 21 ECOSYSTEM MARKET MAP: TELEHEALTH & TELEMEDICINE MARKET 97
5.7 VALUE CHAIN ANALYSIS 98
FIGURE 22 VALUE CHAIN ANALYSIS: TELEHEALTH & TELEMEDICINE MARKET 99
5.8 PORTER’S FIVE FORCES ANALYSIS 99
TABLE 7 PORTER’S FIVE FORCES ANALYSIS: TELEHEALTH & TELEMEDICINE MARKET 99
5.8.1 THREAT OF NEW ENTRANTS 100
5.8.2 THREAT OF SUBSTITUTES 100
5.8.3 BARGAINING POWER OF BUYERS 100
5.8.4 BARGAINING POWER OF SUPPLIERS 100
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 100
5.9 PATENT ANALYSIS 100
5.9.1 PATENT PUBLICATION TRENDS 100
FIGURE 23 PATENT PUBLICATION TRENDS, 2014–2023 101
5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 101
FIGURE 24 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR TELEHEALTH & TELEMEDICINE PATENTS, JANUARY 2013– NOVEMBER 2023 102
FIGURE 25 TOP APPLICANT COUNTRIES/REGIONS FOR TELEHEALTH & TELEMEDICINE PATENTS, JANUARY 2014–OCTOBER 2023 102
5.9.3 LIST OF MAJOR PATENTS 103
TABLE 8 KEY PATENTS IN TELEHEALTH & TELEMEDICINE MARKET 103
5.10 TARIFF & REGULATORY LANDSCAPE 104
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 105
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
TABLE 12 REGULATORY STANDARDS IN TELEHEALTH & TELEMEDICINE MARKET 107
5.10.2 REGULATORY ANALYSIS 108
TABLE 13 REGULATORY REQUIREMENTS IN NORTH AMERICA 108
TABLE 14 REGULATORY REQUIREMENTS IN EUROPE 109
TABLE 15 REGULATORY REQUIREMENTS IN ASIA PACIFIC 109
TABLE 16 REGULATORY REQUIREMENTS IN LATIN AMERICA 110
TABLE 17 REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA 110
5.11 TRADE ANALYSIS 111
5.11.1 TRADE ANALYSIS FOR TELEHEALTH & TELEMEDICINE DEVICES 111
FIGURE 26 IMPORTS OF PRODUCTS UNDER HSN CODE 90189099, BY COUNTRY, 2022 (USD THOUSAND) 111
FIGURE 27 EXPORTS OF PRODUCTS UNDER HSN CODE 90189099, BY COUNTRY, 2022 (USD THOUSAND) 112
5.12 PRICING ANALYSIS 112
5.12.1 COSTS INVOLVED IN TELEMEDICINE DEVICES 112
5.12.2 AVERAGE SELLING PRICE FOR TELEHEALTH & TELEMEDICINE DEVICES, BY KEY PLAYER 113
5.12.3 INDICATIVE PRICING ANALYSIS OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION 113
5.12.4 PRICING MODELS 113
5.13 REIMBURSEMENT ANALYSIS 114
5.13.1 TYPES OF VIRTUAL SERVICES TO MEDICARE BENEFICIARIES 114
TABLE 18 MEDICARE TELEMEDICINE SERVICES AND HCPCS/CPT CODES 114
5.14 INVESTMENT LANDSCAPE 115
FIGURE 28 INVESTOR DEALS AND FUNDING IN TELEHEALTH & TELEMEDICINE DROPPED IN 2022 115
FIGURE 29 TOP FUNDED GLOBAL DIGITAL HEALTH CATEGORIES IN 2021 116
FIGURE 30 MOST VALUED TELEHEALTH & TELEMEDICINE FIRMS IN 2022 (USD BILLION) 117
5.15 KEY CONFERENCES & EVENTS 117
TABLE 19 LIST OF KEY CONFERENCES & EVENTS, 2023–2024 117
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 118
FIGURE 31 REVENUE SHIFT IN TELEHEALTH & TELEMEDICINE MARKET 118
5.17 KEY STAKEHOLDERS & BUYING CRITERIA 119
5.17.1 KEY STAKEHOLDERS 119
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 119
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 119
5.17.2 BUYING CRITERIA 120
FIGURE 33 KEY BUYING CRITERIA 120
TABLE 21 KEY BUYING CRITERIA FOR TELEHEALTH & TELEMEDICINE MARKET 120
5.18 UNMET NEEDS 121
TABLE 22 UNMET NEED IN TELEHEALTH & TELEMEDICINE MARKET 121
6 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT 123
6.1 INTRODUCTION 124
TABLE 23 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 124
6.2 SOFTWARE & SERVICES 124
TABLE 24 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 25 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 26 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 27 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 28 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 29 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 30 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 127
6.2.1 SOFTWARE & SERVICES, BY TYPE 127
6.2.1.1 Remote patient monitoring 127
6.2.1.1.1 Convenience of tracking patient vitals from different places to drive segment 127
TABLE 31 REMOTE PATIENT MONITORING MARKET, BY REGION,
2021–2028 (USD MILLION) 129
6.2.1.2 Real-time interaction 129
6.2.1.2.1 Synchronous nature and potential for better healthcare access to drive segment 129
TABLE 32 REAL-TIME INTERACTION MARKET, BY REGION, 2021–2028 (USD MILLION) 130
6.2.1.3 Store and forward 130
6.2.1.3.1 Easy monitoring of vital signs for long-term chronic care without physical presence to drive segment 130
TABLE 33 STORE AND FORWARD MARKET, BY REGION, 2021–2028 (USD MILLION) 131
6.2.2 SOFTWARE & SERVICES, BY REVENUE MODEL 131
TABLE 34 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 131
6.2.2.1 One-time purchase 132
6.2.2.1.1 Increasing government funding and collaborations with healthcare organizations in rural areas to drive segment 132
TABLE 35 ONE-TIME PURCHASE MARKET, BY REGION, 2021–2028 (USD MILLION) 132
6.2.2.2 Subscription-based 133
6.2.2.2.1 Technological advancements and fixed recurring fees for telehealth consultations to drive segment 133
TABLE 36 SUBSCRIPTION-BASED MARKET, BY REGION, 2021–2028 (USD MILLION) 133
6.2.2.3 Pay-per-use 133
6.2.2.3.1 Lack of adequate reimbursement policies to limit segment 133
TABLE 37 PAY-PER-USE MARKET, BY REGION, 2021–2028 (USD MILLION) 134
6.3 HARDWARE 134
TABLE 38 TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 39 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 40 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 41 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 42 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 43 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 44 TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 137
6.3.1 MONITORS 137
6.3.1.1 Increase in remote monitoring and rising adoption of telemedicine devices to drive segment 137
TABLE 45 MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 137
6.3.2 MEDICAL PERIPHERAL DEVICES 138
TABLE 46 MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 47 MEDICAL PERIPHERAL DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 139
6.3.2.1 Blood pressure monitors 139
6.3.2.1.1 Increasing prevalence of hypertension and obesity to drive segment 139
TABLE 48 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 140
6.3.2.2 Blood glucose meters 140
6.3.2.2.1 Growth in diabetic population to drive segment 140
TABLE 49 BLOOD GLUCOSE METERS MARKET, BY REGION, 2021–2028 (USD MILLION) 141
6.3.2.3 Weight scales 141
6.3.2.3.1 Increasing prevalence of obesity to drive segment 141
TABLE 50 WEIGHT SCALES MARKET, BY REGION, 2021–2028 (USD MILLION) 142
6.3.2.4 Pulse oximeters 142
6.3.2.4.1 Rising awareness about self-monitoring and ease of usage to drive segment 142
TABLE 51 PULSE OXIMETER MARKET, BY REGION, 2021–2028 (USD MILLION) 142
6.3.2.5 Peak flow meters 143
6.3.2.5.1 Rapid assessment of lung conditions and growth in respiratory complications to drive segment 143
TABLE 52 PEAK FLOW METERS MARKET, BY REGION, 2021–2028 (USD MILLION) 143
6.3.2.6 ECG monitors 143
6.3.2.6.1 Rising incidence of cardiovascular diseases to drive segment 143
TABLE 53 ECG MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 144
6.3.2.7 Other medical peripheral devices 144
TABLE 54 OTHER MEDICAL PERIPHERAL PRODUCTS OFFERED BY KEY PLAYERS 144
TABLE 55 OTHER MEDICAL PERIPHERAL DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 145
7 TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY 146
7.1 INTRODUCTION 147
TABLE 56 TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 147
7.2 CLOUD-BASED DELIVERY 147
7.2.1 CLOUD-BASED DELIVERY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 147
TABLE 57 TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY REGION, 2021–2028 (USD MILLION) 148
TABLE 58 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 59 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 60 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 61 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 62 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 150
7.3 ON-PREMISE DELIVERY 150
7.3.1 ENHANCED CONTROL OF SOFTWARE AND EASY REUSE OF EXISTING INFRASTRUCTURE TO DRIVE MARKET 150
TABLE 63 TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY REGION, 2021–2028 (USD MILLION) 151
TABLE 64 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 65 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 66 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 67 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 68 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 153
8 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION 154
8.1 INTRODUCTION 155
TABLE 69 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
8.2 TELECONSULTATION 155
8.2.1 INCREASED NEED FOR AT-HOME FACILITIES AND SHORTAGE OF MEDICAL STAFF TO DRIVE MARKET 155
TABLE 70 TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY REGION, 2021–2028 (USD MILLION) 156
TABLE 71 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 72 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 73 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 74 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 75 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION) 158
8.3 TELEICU 158
8.3.1 INCREASING NUMBER OF PATIENTS IN EMERGENCY DEPARTMENTS AND STAFF SHORTAGE IN RURAL AREAS TO DRIVE MARKET 158
TABLE 76 TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY REGION, 2021–2028 (USD MILLION) 159
TABLE 77 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 78 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 79 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 80 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 81 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION) 161
8.4 TELEPSYCHIATRY 162
8.4.1 SHORTAGE OF MENTAL HEALTH PRACTITIONERS AND FAVORABLE REIMBURSEMENT SCENARIO TO DRIVE MARKET 162
TABLE 82 TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 83 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 84 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 85 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 86 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION) 165
TABLE 87 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION) 165
8.5 TELERADIOLOGY 165
8.5.1 TELERADIOLOGY TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 165
TABLE 88 TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY REGION, 2021–2028 (USD MILLION) 166
TABLE 89 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 90 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 91 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 92 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 93 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 168
8.6 TELESTROKE 169
8.6.1 RISING INCIDENCE OF STROKE AND INCREASING GERIATRIC POPULATION TO DRIVE MARKET 169
TABLE 94 TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY REGION, 2021–2028 (USD MILLION) 169
TABLE 95 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION) 169
TABLE 96 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 97 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 98 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 99 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION) 171

8.7 TELEDERMATOLOGY 171
8.7.1 RISING PREVALENCE OF SKIN DISEASES AND GROWING USE OF HD CAMERAS FOR SKIN DIAGNOSIS TO DRIVE MARKET 171
TABLE 100 TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY REGION, 2021–2028 (USD MILLION) 172
TABLE 101 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 102 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 103 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 104 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 174
TABLE 105 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 174
8.8 OTHER APPLICATIONS 175
TABLE 106 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 175
TABLE 107 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 108 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 176
TABLE 109 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 176
TABLE 110 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 111 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 177
9 TELEHEALTH & TELEMEDICINE MARKET, BY END USER 178
9.1 INTRODUCTION 179
TABLE 112 TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 179
9.2 PROVIDERS 179
TABLE 113 TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 114 TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY REGION, 2021–2028 (USD MILLION) 180
TABLE 115 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 180
TABLE 116 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 117 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 118 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY REGION, 2021–2028 (USD MILLION) 182
TABLE 119 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 182
9.2.1 HOSPITALS & CLINICS 182
9.2.1.1 Growing incidence of chronic diseases and rising demand for high-quality care to drive segment 182
TABLE 120 HOSPITALS & CLINICS MARKET, BY REGION, 2021–2028 (USD MILLION) 183
9.2.2 LONG-TERM CARE CENTERS AND ASSISTED LIVING FACILITIES 183
9.2.2.1 Increasing geriatric population and rising need for prolonged treatment for chronic diseases to drive segment 183
TABLE 121 LONG-TERM CARE CENTERS AND ASSISTED LIVING FACILITIES MARKET, BY REGION, 2021–2028 (USD MILLION) 184
9.3 PAYERS 184
TABLE 122 TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 185
TABLE 123 TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY REGION, 2021–2028 (USD MILLION) 185
TABLE 124 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 185
TABLE 125 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 126 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 127 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 128 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 187
9.3.1 PUBLIC PAYERS 187
9.3.1.1 Increasing investments by public payers to drive segment 187
TABLE 129 PUBLIC PAYERS MARKET, BY REGION, 2021–2028 (USD MILLION) 188
9.3.2 PRIVATE PAYERS 188
9.3.2.1 Expansion of telehealth services to mental health and substance usage to drive segment 188
TABLE 130 PRIVATE PAYERS MARKET, BY REGION, 2021–2028 (USD MILLION) 189
9.4 PATIENTS 189
9.4.1 RISING PREVALENCE OF CHRONIC DISEASES AND EMERGENCE OF ADVANCED WEARABLE MONITORS TO DRIVE MARKET 189
TABLE 131 TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY REGION, 2021–2028 (USD MILLION) 190
TABLE 132 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 133 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 134 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 135 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 136 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 192

9.5 OTHER END USERS 192
TABLE 137 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 193
TABLE 138 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 193
TABLE 139 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 194
TABLE 140 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 194
TABLE 141 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 142 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 195
10 TELEHEALTH & TELEMEDICINE MARKET, BY REGION 196
10.1 INTRODUCTION 197
FIGURE 34 GEOGRAPHIC SNAPSHOT: TELEHEALTH & TELEMEDICINE MARKET, 2022 197
TABLE 143 TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2021–2028 (USD MILLION) 198
10.2 NORTH AMERICA 198
FIGURE 35 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT 199
TABLE 144 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 200
TABLE 145 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 200
TABLE 146 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 147 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 201
TABLE 148 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 149 NORTH AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 150 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 202
TABLE 151 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 203
TABLE 152 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 203
TABLE 153 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 204
TABLE 154 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 204
10.2.1 NORTH AMERICA: RECESSION IMPACT 204
10.2.2 US 205
10.2.2.1 US to dominate North American market during forecast period 205
TABLE 155 US: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 207
TABLE 156 US: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 157 US: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 207
TABLE 158 US: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 159 US: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 160 US: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 209
TABLE 161 US: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 209
TABLE 162 US: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 210
TABLE 163 US: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 210
TABLE 164 US: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 210
10.2.3 CANADA 211
10.2.3.1 Increasing geriatric population and rising government healthcare expenditure to drive market 211
TABLE 165 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 212
TABLE 166 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 167 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 212
TABLE 168 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 169 CANADA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 170 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 213
TABLE 171 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 214
TABLE 172 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 214
TABLE 173 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 215
TABLE 174 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 215

ページTOPに戻る

Table of Contents

Summary

The Telehealth and Telemedicine market is projected to reach USD 285.7 billion by 2028 from USD 120.4 billion in 2023, at a CAGR of 23.2% during the forecast period. The growth of telemedicine and telehealth is propelled by increased accessibility to healthcare services, especially in remote areas, and continuous technological advancements, such as improved connectivity and enhanced platforms, fostering better patient engagement and outcomes.

“Cloud based delivery mode segment accounted for a substantial share of the Telehealth and Telemedicine market, by delivery mode in 2022.”
The cloud-based delivery mode is expected to account for the largest share of 78.2% of the global telehealth and telemedicine market in 2022. It is projected to grow at the highest CAGR of 28.6 % during the forecast period. Cloud-based delivery dominates the telehealth and telemedicine market due to its inherent advantages. The accessibility and scalability offered by cloud solutions enable healthcare services from virtually anywhere, bridging gaps in remote or underserved areas. Cost efficiency is heightened through subscription-based models, making these platforms attractive for organizations with budget constraints. Robust security measures, compliance standards, and seamless interoperability make cloud environments secure repositories for sensitive patient data. Real-time collaboration, remote monitoring capabilities, and rapid deployment further enhance the effectiveness of telehealth services. Additionally, cloud platforms ensure quick updates, disaster recovery, and business continuity, collectively driving their widespread adoption in the evolving landscape of healthcare delivery.

“Software and service segment accounted for a substantial share of the Telehealth and Telemedicine market, by component in 2022.”
Based on components, the software & services segment is expected to account for the largest share of 71.3% of the global telehealth and telemedicine market in 2022. The software and services segment holds a significant share as a component in the telehealth and telemedicine market. This prominence is driven by the crucial role that software applications and associated services play in facilitating remote healthcare delivery. Telehealth platforms rely heavily on advanced software solutions to enable virtual consultations, patient monitoring, and seamless data exchange. Additionally, the provision of supportive services such as telemedicine consultation support, data analytics, and integration services further solidifies the importance of the software and services component. As the telehealth and telemedicine landscape continues to evolve, the software and services segment remains a cornerstone, contributing substantially to the market's growth and efficacy.
“Providers segment accounted for a considerable share in the Telehealth and Telemedicine market, by end user in 2022”
In 2022, the provider segment played a significant role in the telehealth and telemedicine market, contributing to a substantial share. This prominence is attributed to This is attributed to the increased adoption of remote monitoring for chronically ill and old aged patients, advancements in telehealth monitoring devices, and the increased number of telespecialty services offered by providers..

“Teleradiology segment accounted for the largest share in Telehealth and Telemedicine market by Application in 2022”
In 2022, teleradiology segment emerged as the leading contributor to the Telehealth and Telemedicine market, holding the largest share. Factors such as an increase in imaging practices, an increase in teleradiology workflow adoption by healthcare providers, and the streamlining and regulation of teleradiology practices are driving the market growth. The teleradiology segment is expected to account for the largest share of 22.2% of the global telehealth and telemedicine market in 2022.
“North America to witness the substantial growth rate during the forecast period.”
The global market is led by the United States, experiencing a noteworthy CAGR of 24.3% and reaching a valuation of US$ 289.7 billion in the forecast period. The surge is propelled by factors such as the prevalence of chronic diseases, an aging population, and cost-effective healthcare services, contributing to the growth of telehealth and telemedicine in the United States. The market sees continuous expansion due to increased healthcare infrastructure, expenditures, and innovative technologies. Government initiatives and the active involvement of key vendors further amplify market size, marking a substantial increase from the historical CAGR of 24.3% between 2023 and 2028.

The break-down of primary participants is as mentioned below:
• By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
• By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, ROW-10%

Key Players in the Telehealth and Telemedicine Solutions Market
Prominent players in the Telehealth and Telemedicine market include Koninklijke Philips, N.V (Netherlands), Medtronic plc (Ireland), GE Healthcare (US), Oracle (US), Siemens Healthcare GmbH (Germany), Cisco Systems (US), Asahi Kasei Corporation (Japan), Iron Bow Technologies (US), American Well (US), Teladoc Health, Inc. (US), AMC Health (US), TeleSpecialists(US), Doctor On Demand by Included Health, Inc. (US), MDLIVE (US), GlobalMedia Group, LLC (US), Medvivo Group Ltd. (UK), Medweb(US), VSee (US), Imedi Plus (China), Zipnosis (US), ACL Digital (US), iCliniq (US), Boston Scientific Cardiac Diagnostics Inc. (US), Resideo Technologies Inc.(US).
Research Coverage:
The report analyzes the Telehealth and Telemedicine Market and aims to estimate the market size and future growth potential of various market segments, based on components,mode of delivery, application , end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
 Analysis of key drivers (Growing geriatric population and need to expand healthcare access, Rising prevalence of chronic conditions and cost-benefits of telehealth and telemedicine, Shortage of physicians, Advancements in telecommunications, and Government support and rising awareness), restraints (regulatory variations across regions, fraud in telemedicine and telehealth), opportunities (High utility in combating infectious diseases and epidemics, use of innovative technologies like blockchain, AI and virtual assistants), and challenges (Inability to ascertain hygiene and cleanlinessinfluencing the growth of the Telehealth and Telemedicine market.
 Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the Telehealth and Telemedicine market.
 Market Development: Comprehensive information on the lucrative emerging markets, component, demographics , end-user, and region.
 Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the Telehealth and Telemedicine market
 Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the Telehealth and Telemedicine market like Koninklijke Philips, N.V (Netherlands), Medtronic plc (Ireland), GE Healthcare (US), Oracle (US), Siemens Healthcare GmbH (Germany), Cisco Systems (US) etc.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（telemedicine）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（telemedicine）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?